Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs has deferred the board meeting originally scheduled for December 9, 2025, which was set to consider a proposal for raising funds through a Rights Issue and/or other permissible modes. The company cited pending preparatory and procedural work, including finalisation of documents, information compilation, and regulatory compliances, as the reason for the postponement. The board will revisit the fund-raising proposal at a later date once these steps are complete. The brief meeting that did take place ran from 5:00 PM to 5:30 PM but did not take up the fund-raising agenda.
No immediate impact on shareholders as no concrete decision on fund-raising has been made. Investors should monitor for the rescheduled meeting date and subsequent disclosures regarding the potential equity issuance, which could lead to dilution if it proceeds.